Effects of combined test dose and therapeutic drug monitoring strategy in exposure-directed busulfan.
Iemura T, Kondo T, Ueda A, Maeda T, Kitawaki T, Arai Y, Kanda J, Ikeda T, Imada K, Ishikawa T, Anzai N, Itoh M, Takeoka T, Akasaka T, Yago K, Yonezawa A, Arima N, Kitano T, Nohgawa M, Watanabe M, Moriguchi T, Yamashita K, Ueda Y, Matsumoto K, Takaori-Kondo A.
Iemura T, et al. Among authors: kitawaki t.
Ann Hematol. 2023 Oct;102(10):2909-2922. doi: 10.1007/s00277-023-05209-2. Epub 2023 Apr 13.
Ann Hematol. 2023.
PMID: 37052663
Clinical Trial.